BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10938895)

  • 1. Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects.
    Weber AA; Liesener S; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2000 May; 11(3):177-82. PubMed ID: 10938895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers.
    Rångemark C; Wennmalm A
    Clin Physiol; 1996 May; 16(3):301-15. PubMed ID: 8736716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin.
    Ring ME; Corrigan JJ; Fenster PE
    Thromb Res; 1986 Nov; 44(3):391-400. PubMed ID: 3798404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets of habitual smokers have reduced susceptibility to aggregating agent.
    Foo LC; Roshidah I; Aimy MB
    Thromb Haemost; 1991 Mar; 65(3):317-9. PubMed ID: 2048056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment.
    Valles J; Santos MT; Aznar J; Marcus AJ; Martinez-Sales V; Portoles M; Broekman MJ; Safier LB
    Blood; 1991 Jul; 78(1):154-62. PubMed ID: 1712639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA; Devitt M; Bonnar J
    Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of aspirin to impair bovine platelet function.
    Gentry PA; Tremblay RR; Ross ML
    Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.
    Pulcinelli FM; Riondino S; Celestini A; Pignatelli P; Trifirò E; Di Renzo L; Violi F
    J Thromb Haemost; 2005 Dec; 3(12):2784-9. PubMed ID: 16359516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Arterioscler Thromb; 1991; 11(3):610-6. PubMed ID: 2029501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men.
    Jimenez AH; Stubbs ME; Tofler GH; Winther K; Williams GH; Muller JE
    Am J Cardiol; 1992 Jan; 69(3):258-62. PubMed ID: 1731469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.
    Cornelissen J; Kirtland S; Lim E; Goddard M; Bellm S; Sheridan K; Large S; Vuylsteke A
    Thromb Haemost; 2006 Mar; 95(3):476-82. PubMed ID: 16525576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
    Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
    Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.